Cargando…

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)

The European Association for the Study of the Liver has produced extensive guidelines for the investigation and management of drug-induced liver injury. Here, we provide a commentary and overview of some of the principle disease investigations and management that arise from these guideline recommend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brennan, Paul N, Cartlidge, Peter, Manship, Thomas, Dillon, John F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Liver
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186030/ https://www.ncbi.nlm.nih.gov/pubmed/35722609 http://dx.doi.org/10.1136/flgastro-2021-101886

Ejemplares similares

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study
por: Agbim, Uchenna, et al.
Publicado: (2020)

Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation
por: Millson, Charles, et al.
Publicado: (2020)

Adult liver transplantation: A UK clinical guideline - part 1: pre-operation
por: Millson, Charles, et al.
Publicado: (2020)

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Publicado: (2016)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients
por: Harrington, Claire, et al.
Publicado: (2022)

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
por: Tátrai, Péter, et al.
Publicado: (2022)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022)

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives
por: Kuna, Lucija, et al.
Publicado: (2018)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014)

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
por: Villanueva-Paz, Marina, et al.
Publicado: (2021)

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
por: Liu, Anika, et al.
Publicado: (2021)

A novel phenotype‐based drug‐induced liver injury causality assessment tool (DILI‐CAT) allows for signal confirmation in early drug development
por: Hermann, Richard P., et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis
por: Sanchez, Lukas Otero, et al.
Publicado: (2021)

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
por: Walker, Paul A., et al.
Publicado: (2020)

Advances and Emerging Therapies in the Treatment of Non-alcoholic Steatohepatitis
por: Brennan, Paul N, et al.
Publicado: (2022)

The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)

DILI( C ): An AI-Based Classifier to Search for Drug-Induced Liver Injury Literature
por: Rathee, Sanjay, et al.
Publicado: (2022)

Infliximab (IFX)-Biosimilar Induced Drug-Induced Liver Injury (DILI): A Case Report
por: Zachou, Maria, et al.
Publicado: (2022)

Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013)

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
por: Segovia-Zafra, Antonio, et al.
Publicado: (2021)

Selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): informing clinical practice for multidisciplinary teams in England
por: Reeves, Helen L, et al.
Publicado: (2022)

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
por: Yeon, Jong Eun
Publicado: (2018)

Donor acquired visceral leishmaniasis following liver transplantation
por: Dhaliwal, Amritpal, et al.
Publicado: (2021)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

Humoral and cellular immune responses to SARS-CoV-2 vaccination across multiple vaccine platforms and liver disease types: an EASL registry multicentre prospective cohort study
por: Marjot, Thomas, et al.
Publicado: (2022)

Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations
por: Kleiner, David E, et al.
Publicado: (2014)

2409. Drug-Induced Liver Injury (DILI) in a National Cohort of Hospitalized Patients Treated With Aztreonam and Ceftazidime
por: Saade, Elie, et al.
Publicado: (2018)

Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints
por: Liu, Xiaobin, et al.
Publicado: (2020)

Medical liver biopsy: background, indications, procedure and histopathology
por: Boyd, Alexander, et al.
Publicado: (2019)

Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma
por: Meischl, Tobias, et al.
Publicado: (2021)

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)
por: Hudson, Mark, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_151jpgv84r5q75tll8m46uli0d